Skip to main content Accessibility help
  • Print publication year: 2015
  • Online publication date: May 2015

Chapter 14 - Optical coherence tomography and retinal pathology in neurologic diseases

Related content

Powered by UNSILO
1.Green, AJ. Mcquaid, S, Hauser, SL, et al Ocular pathology in multiple sclerosis: retinal atrophy and inflammation irrespective of disease duration. Brain 2010; 133 (Pt 6): 15911601.
2.Oppenheim, H. Zur pathologie der disseminirten sklerose. Berliner Klinische Wochenschrift 1887; 48:904–7.
3.Lisch, K. Die Veranderung der peripheren schbahn bei Mulipler Sklerose Arch f. Augehn 1933;107:380.
4.Gartner, S. Optic neuropathy in multiple sclerosis; optic neuritis. AMA Arch Ophthalmol December 1953;50(6):718–26.
5.Toussaint, D, Périer, O, Verstappen, A, Bervoets, S. Clinicopathological study of the visual pathways, eyes, and cerebral hemispheres in 32 cases of disseminated sclerosis. J Clin Neuroophthalmol September 1983;3(3):211–20.
6.Kerrison, JB, Flynn, T, Green, WR. Retinal pathologic changes in multiple sclerosis. Retina 1994;14(5):445–51.
7.Mogensen, PH. Histopathology of anterior parts of the optic pathway in patients with multiple sclerose. Acta Ophthalmol (Copenh) April 1990;68(2):218–20.
8.ter Braak, JWG, van Herwaarden, A. Ophthalmo encephalomyelitis. Klin Monatsbl Augenheilkd 1933;91:316–43.
9.Rucker, CW. Sheathing of the retinal veins in multiple sclerosis. Review of pertinent literature. Mayo Clin Proc 1972;47:335–40.
10.Toussaint, D. Perivenous sheathing in multiple sclerosis. Bull Soc Belge Ophtalmol. November 1983;208 Pt 1:369–74.
11Sanders, MD. Retinal arteritis, retinal vasculitis and autoimmune retinal vasculitis. Eye 1987;1:441–65
12.Arnold, AC, Pepose, JS, Hepler, RS, Foos, RY. Retinal periphlebitis and retinitis in multiple sclerosis. I. Pathologic characteristics. Ophthalmology 1984; 91:255–62.
13.Evangelou, N, Konz, D, Esiri, MM, et al. Size-selective neuronal changes in the anterior optic pathways suggest a differential susceptibility to injury in multiple sclerosis. Brain 2001;124:1813–20.
14.Schlamp, CL, Montgomery, AD, Mac Nair, CE, et al. Evaluation of the percentage of ganglion cells in the ganglion cell layer of the rodent retina. Mol Vis June 27, 2013;19:1387–96.
15.Wang, L, Cioffi, GA, Cull, G, Dong, J, Fortune, B. Immunohistologic evidence for retinal glial cell changes in human glaucoma. Invest Ophthalmol Vis Sci April 2002;43(4):1088–94.
16.Liu, S, Li, ZW, Weinreb, RN, Xu, G, et al. Tracking retinal microgliosis in models of retinal ganglion cell damage. Invest Ophthalmol Vis Sci September 2012;53 (10):6254–62.
17.Anderson, GW, Goebel, HH, Simonati, A. Human pathology in NCL. Biochim Biophys Acta November 2013;1832(11):1807–26.
18.Seehafer, SS, Pearce, DA. You say lipofuscin, we say ceroid: defining autofluorescent storage material. Neurobiol Aging April 2006;27(4):576–88.
19.Bensaoula, T, Shibuya, H, Katz, ML, Smith, JE, Johnson, GS, John, SK, Milam, AH. Histopathologic and immunocytochemical analysis of the retina and ocular tissues in Batten disease. Ophthalmology September 2000;107(9):1746–53.
20.Goebel, HH, Fix, JD, Zeman, W. The fine structure of the retina in neuronal ceroid-lipofuscinosis. Am J Ophthalmol January 1974;77(1):2539.
21.Cogan, DG. Visual disturbances with focal progressive dementing disease. Am J Ophthalmol July 15, 1985;100(1): 6872.
22.Tzekov, R, Mullan, M. Vision function abnormalities in Alzheimer disease. Surv Ophthalmol October 22, 2013. pii: S0039–6257(13) 00237–3.
23.Hedges, TR 3rd, Perez Galves, R, Speigelman, D, et al. Retinal nerve fiber layer abnormalities in Alzheimer’s disease. Acta Ophthalmol Scand June 1996;74(3):271–5.
24.Tsai, CS, Ritch, R, Schwartz, B, Lee, SS, et al. Optic nerve head and nerve fiber layer in Alzheimer’s disease. Arch Ophthalmol February 1991;109(2):199204.
25.Lu, Y, Li, Z, Zhang, X, Ming, B, et al. Retinal nerve fiber layer structure abnormalities in early Alzheimer’s disease: evidence in optical coherence tomography. Neurosci Lett August 9, 2010 Aug 9;480(1):6972.
26.Kesler, A, Vakhapova, V, Korczyn, AD, et al. Retinal thickness in patients with mild cognitive impairment and Alzheimer’s disease. Clin Neurol Neurosurg September 2011;113(7):523–6.
27.Berisha, F, Feke, GT, Trempe, CL, et al. Retinal abnormalities in early Alzheimer’s disease. Invest Ophthalmol Vis Sci May 2007;48(5):2285–9.
28.Hinton, DR, Sadun, AA, Blanks, JC, Miller, CA. Optic-nerve degeneration in Alzheimer’s disease. N Engl J Med August 21, 1986;315(8):485–7.
29.Blanks, JC, Torigoe, Y, Hinton, DR, Blanks, RH. Retinal degeneration in the macula of patients with Alzheimer’s disease. Ann N Y Acad Sci 1991;640:44–6.
30.Blanks, JC, Torigoe, Y, Hinton, DR, Blanks, RH. Retinal pathology in Alzheimer’s disease. I. Ganglion cell loss in foveal/parafoveal retina. Neurobiol Aging May-June 1996;17(3):377–84.
31.Blanks, JC, Schmidt, SY, Torigoe, Y, et al. Retinal pathology in Alzheimer’s disease. II. Regional neuron loss and glial changes in GCL. Neurobiol Aging. May-June 1996;17(3):385–95.
32.Curcio, CA, Drucker, DN. Retinal ganglion cells in Alzheimer’s disease and aging. Ann Neurol March 1993;33(3):248–57.
33.Hoh Kam, J, Lenassi, E, Jeffery, G. Viewing ageing eyes: diverse sites of amyloid Beta accumulation in the ageing mouse retina and the up-regulation of macrophages. PLoS One October 1, 2010;5(10).
34.Koronyo-Hamaoui, M, Koronyo, Y, Ljubimov, AV, et al. Identification of amyloid plaques in retinas from Alzheimer’s patients and noninvasive in vivo optical imaging of retinal plaques in a mouse model. Neuroimage January 2011; 54 Suppl 1:S204–17.
35.Koronyo, Y, Salumbides, BC, Black, KL, Koronyo-Hamaoui, M. Alzheimer’s disease in the retina: imaging retinal aβ plaques for early diagnosis and therapy assessment. Neurodegener Dis 2012;10(14):285–93.
36.Ho, CY, Troncoso, JC, Knox, D, et al. Beta-amyloid, phospho-tau and alpha-synuclein deposits similar to those in the brain are not identified in the eyes of Alzheimer’s and Parkinson’s disease patients. Brain Pathol January 2014;24(1):2532.
37.Alexandrov, PN, Pogue, A, Bhattacharjee, S, Lukiw, WJ. Retinal amyloid peptides and complement factor H in transgenic models of Alzheimer’s disease. Neuroreport August 24, 2011;22(12):623–7
38.Fortuna, F, Barboni, P, Liguori, R, et al. Visual system involvement in patients with Friedreich’s ataxia. Brain January 2009;132(Pt 1):116–23.
39.Noval, S, Contreras, I, Sanz-Gallego, I, et al. Ophthalmic features of Friedreich ataxia. Eye (Lond) February 2012;26(2):315–20.
40.Tatton, WG, Kwan, MM, Verrier, MC, et al. MPTP produces reversible disappearance of tyrosine hydroxylase-containing retinal amacrine cells. Brain Res September 10, 1990;527(1):2131.
41.Archibald, NK, Clarke, MP, Mosimann, UP, Burn, DJ. The retina in Parkinson’s disease. Brain May 2009;132 (Pt 5):1128–45.
42.Maurage, CA, Ruchoux, MM, de Vos, R, et al. Retinal involvement in dementia with Lewy bodies: a clue to hallucinations? Ann Neurol October 2003;54(4):542–7.
43.Paulus, W, Schwarz, G, Werner, A, et al. Impairment of retinal increment thresholds in Huntington’s disease. Ann Neurol October 1993;34(4):574–8
44.Petrasch-Parwez, E, Saft, C, Schlichting, A, et al. Is the retina affected in Huntington disease? Acta Neuropathol November 2005;110(5):523–5.
45.Jackson, GR, Salecker, I, Dong, X, et al Polyglutamine-expanded human huntingtin transgenes induce degeneration of Drosophila photoreceptor neurons. Neuron September 1998;21(3):633–42.
46.Martin, JJ, Van Regemorter, N, Krols, L, et al. On an autosomal dominant form of retinal-cerebellar degeneration: an autopsy study of five patients in one family. Acta Neuropathol 1994;88(4):277–86.
47.Agamanolis, DP, Chester, EM, Victor, M, et al. Neuropathology of experimental vitamin B12 deficiency in monkeys. Neurology October 1976;26(10):905–14.
48.Smiddy, WE, Green, WR. Nutritional amblyopia. A histopathologic study with retrospective clinical correlation. Graefes Arch Clin Exp Ophthalmol 1987;225 (5):321–4.
49.Victor, M, Dreyfus, PM. Tobacco-alcohol amblyopia. Further comments on its pathology. Arch Ophthalmol. November 1965;74(5):649–57.
50.Sharpe, JA, Hostovsky, M, Bilbao, JM, Rewcastle, NB. Methanol optic neuropathy: a histopathological study. Neurology October 1982;32(10):1093–100.
51.Curcio, CA. Photoreceptor topography in ageing and age-related maculopathy. Eye(Lond) June 2001;15(Pt 3):376–83.
52.Pitts, DG. The effects of aging on selected visual functions: dark adaptation, visual acuity, stereopsis and brightness contrast. In: Sekuler, R, Kline, DW, Dismukes, K, editors. Aging and Human Visual Function. New York: 1982; p. 131159.
53.Leger, F, Fernagut, PO, Canron, MH, et al. Protein aggregation in the aging retina. J Neuropathol Exp Neurol January 2011;70(1):63–8.